IBB vs. XBIT
IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while XBIT (XBiotech Inc.) is a stock. Over the past 10 years, IBB returned 6.23%/yr vs -16.44%/yr for XBIT. At a 0.30 correlation, their price movements are largely independent.
Performance
IBB vs. XBIT - Performance Comparison
Loading charts...
Returns By Period
Over the past 10 years, IBB has outperformed XBIT with an annualized return of 6.23%, while XBIT has yielded a comparatively lower -16.44% annualized return.
IBB
- 1D
- 1.97%
- 1M
- -1.56%
- YTD
- -0.68%
- 6M
- -2.57%
- 1Y
- 34.50%
- 3Y*
- 9.40%
- 5Y*
- 2.10%
- 10Y*
- 6.23%
XBIT
- 1D
- -0.83%
- 1M
- -6.27%
- YTD
- 0.00%
- 6M
- -7.72%
- 1Y
- -17.30%
- 3Y*
- -22.38%
- 5Y*
- -30.37%
- 10Y*
- -16.44%
IBB vs. XBIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | -0.68% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
XBIT XBiotech Inc. | 0.00% | -39.49% | -1.25% | 13.96% | -68.46% | -17.46% | -16.15% | 267.42% | 28.93% | -61.07% |
Correlation
The correlation between IBB and XBIT is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. XBIT — Risk / Return Rank
IBB
XBIT
IBB vs. XBIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBB | XBIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.08 | ||
| Sortino ratioReturn per unit of downside risk | +2.69 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 0.98 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 3.60 | -0.44 | +4.04 |
| Martin ratioReturn relative to average drawdown | 11.43 | -0.67 | +12.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBB | XBIT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.74 | -0.33 | +2.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.10 | -0.48 | +0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.27 | -0.22 | +0.49 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | -0.22 | +0.48 |
Drawdowns
IBB vs. XBIT - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, smaller than the maximum XBIT drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for IBB and XBIT.
Loading charts...
Drawdown Indicators
| IBB | XBIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -92.67% | +29.82% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -39.43% | +29.80% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -78.56% | +53.71% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -87.21% | +47.39% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | -90.72% | +50.90% |
Current DrawdownCurrent decline from peak | -5.64% | -91.19% | +85.55% |
Average DrawdownAverage peak-to-trough decline | -21.18% | -70.10% | +48.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.03% | 25.84% | -22.81% |
Volatility
IBB vs. XBIT - Volatility Comparison
iShares Nasdaq Biotechnology ETF (IBB) and XBiotech Inc. (XBIT) have volatilities of 6.86% and 6.87%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | XBIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.86% | 6.87% | -0.01% |
Volatility (6M)Calculated over the trailing 6-month period | 15.38% | 27.51% | -12.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.89% | 51.89% | -32.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.99% | 64.04% | -42.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.22% | 75.32% | -52.10% |
Dividends
IBB vs. XBIT - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.23%, while XBIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
XBIT XBiotech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IBB and XBIT have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBIT has higher volatility (6.87%) compared to IBB (6.86%). In terms of maximum drawdown, IBB dropped -62.85% vs XBIT's -92.67%.
IBB currently has the higher Sharpe Ratio (1.74 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and XBIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer